Delivery Order SPE2DB22D3102-SPE2DB24FL2HB

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The $2,565.78 firm fixed-price contract has a completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,658.40 firm fixed-price contract is for the supply of Pediarix 0.5 ML syringes, a pediatric vaccine. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded various federal contracts to provide a wide range of medical products, including specialty medications, drugs, vaccines,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 0.5 ML PEDIARIX syringes. The $10,292.64 contract has a completion date of February 26, 2024 and supports military treatment programs and facilities. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA through December 2025, which serves as the primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $12,323.40 to Amerisourcebergen Drug Corp for the supply of 0.5 mL PEDIARIX vaccine syringes. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $29,016.40, is for the supply of 0.5 mL Pediarix syringes, which are used to administer a pediatric vaccine. The contract has a firm-fixed price pricing type and a completion date of September 4, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pediarix 0.5 ML syringes. The delivery order, valued at $11,829.06, is a Firm Fixed Price contract with a completion date of July 30, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, worth up to $999,999,999 and $750,000 respectively, to provide a range of pharmaceutical...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,086.24 firm fixed-price delivery order is for the supply of Pediarix 0.5 ML syringes, a pediatric combination vaccine. The contract has a completion date of June 28, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pediarix 0.5 ML syringes. The contract, a delivery order valued at $1,797.15, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of September 5, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $2,875.46 firm-fixed-price contract is for the supply of 0.5 mL syringes of the pediatric vaccine Pediarix. The award has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pediarix 0.5 mL syringes. The contract has a ceiling value of $3,652.62 and a period of performance through August 30, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL2HB
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,269.36 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 0.5 mL Pediarix syringes. This contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs and vaccines, to support military treatment facilities and other government healthcare programs. The contract does not have a set-aside designation.

Generated 10/31/24, 10:43 AM